Back to trial details

Intake questionnaire

Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, 6 to <30 mm in Diameter, Determined by LDCT.

Applying to Clinical Research Associates of Central Pennsylvania · DuBois, Pennsylvania

Answer a few short questions to share with the research team.

0 of 3 answered

1. Are you between 50 and 80 years old?
2. Have you been diagnosed with Lung Cancer (Diagnosis)?
3. Are you able to travel to DuBois for study visits?